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1. Introduction
  Reflux esophagitis is a clinical common disease, with the 
rising trend of incidence year by year, along with the life 
and diet structure change[1-5]. The reason for this chronic 
intractable disease is that lower esophageal sphincter 
dysfunction results in reflux of gastric or duodenal contents 
into the esophagus, causing inflammatory lesions of 
esophageal mucosa, may induce serious complications 
such as esophageal stenosis and bleeding[6,7]. Experiments 
showed that, damage and symptoms of esophageal mucosa 
are closely related to the frequency and contact time of 
acid exposure, with pH dependence[8]. The author aimed to 
observe the protective effect of Xuanfudaizhetang on reflux 
esophagitis, esophageal mucosal and the effect on pH value, 
by selecting Wistar rats to establish reflux esophagitis 
model with Xuanfudaizhetang treatment. Then the curative 
effect on esophageal and gastric mucosa and pH value 
change were observed and reported as follows.
2. Materials and methods
2.1. Experimental animal 
  A total of 50 male, clean Wistar rats were selected, and 
they were provided by the Laboratory Animal Center, 
Class 栻, weighting (251.3依42.5) g. They were free to forage 
and drinking. Experimental process of rats  was strictly 
in accordance with ”Regulations on Administration of 
Experimental Animals”.
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2.2. Instruments and reagents
  DigitrapperTMMk 栿 pH Value Recorder (Synectics); Ray 
magnetic PHS-3 c precision pH meter (Shanghai precision 
scientific instrument co., LTD). motilium (yeung sum 
pharmaceutical co., LTD., production); Saline solution (pH = 
7.01); ChanJing blue mixed suspension (tianjin toyo ink co.; 
Xuanfudaizhetang formula: inula spend 9 g, ginger 10 g, 12 g,
jujube, ginseng 6 g, red ochre 30 g, pinellia 9 g, licorice root 
6 g, pan-fried for crude drug concentration of 1 g/mL water 
decoction.
2.3. Model establishment
  Reflux esophagitis model in rats was established by
incomplete helicobacter seam+lower esophagus sphincterotomy
after starvation for 24 h[9]. After intraperitoneal injection 
of urethane anesthesia and abdominal midline incision, 
the stomach was pierced with metal needle through the 
gastric body, from the pylorus to the duodenum. Pylorus 
seam was kept, then metal stitches was taken out. Stomach 
puncture point was stitched. It was incised longitudinally 
in 0.5 cm under the esophageal sphincter to the mucosa for 
strengthening the gastric reflux. All experimental animals 
were provided with food 24 h after surgery.
2.4. Methods 
  A total of 50 Wistar rats were randomly divided into A, B, 
C, D, E groups with 10 in each. After modelling, the rats in 
sham-operated Group A were only given laparotomy; Group 
B is the model group without special treatment; Group C 
was treated with saline lavage; Group D was treated with 
motilium (2 mL/d) for a week; Group E was treated with 
Xuanfudaizhetang lavage 2 mL once a day for a week after 
48 h.
2.5. Indexes observation
  The growth situation and weight changes during treatment 
were observed. One week later, recovery of esophageal, 
gastric mucosa and pH changes of rats were compared 
between groups. After anesthesia and caesarean section, 
a pH recorder electrode was inserted into the stomach big 
bend about 1 cm above the stomach esophagus-junction to 
record the pH; then pH electrode was rinsed with distilled 
water and it was inserted through the distal big bend 
perforation to record the pH. After sacrificing, the lower 
segment of esophagus was collected after saline flushing 
for macroscopic inspection of RE classification, according 
to the Chinese Medical Association Digestive Endoscopy 
Diagnostic Criteria about RE[10]. 1 cm of esophagus at 0.5 cm
above the stomach-esophagus border was collected to 
prepare HE dyeing for pathological RE grading.
2.6. Statistical analysis
  SPSS12.0 statistics software was used for processing data in 
this study; data were expressed as (mean依sd), and analyzed 
by t test. P<0.05 was considered as statistically significant 
difference.
3. Results
3.1. General condition
  Group A revealed luster hair, good appetite and granule 
stool; Group B revealed lacklustre, less appetite abdominal 
distension. General situation of D, E groups of rats was 
close to group A after treatment, body weight was increased 
with the increase of appetite, with weight growth rate of as 
(22.14依3.89) g in group E, (11.91依3.13) g in group D, (13.97依
1.87) g in group C, the difference between three groups was 
statistically significant (P<0.05).
3.2. Pathological morphology changes
  Group A showed complete, smooth and white. The 
esophageal mucosa grades and esophagus tissue pathological 
morphology grades of group D and E were higher than that 
of group B and C with significant difference between groups 
(P<0.05); grades of group D and E shows no significant 
difference between each other. Esophageal mucosa of rats in 
group A had no obvious abnormality of HE staining (Table 1).
Table 1
Esophageal mucosa grades and pathological morphology grades of 
esophagus tissue in the RE rats.
Groups n
Macroscopic inspection 
grades
Pathological morphology 
grades
Group A 10 0.00依0.00 0.00依0.00
Group B 10  2.81依0.42*  2.11依0.74*
Group C 10  2.45依0.73*  2.66依0.50*
Group D 10     0.54依0.67*△     0.35依0.67*△
Group E 10     0.30依0.48*△     0.21依0.42*△
note: *P＜0.05 compared with group A; △P＜0.05 compared with 
group B, C. 
3.3. pH comparision of lower esophageal mucosa and the 
distal mucosa
  There was no significant difference in pH between group 
D and E (P>0.05); pH of lower esophageal mucosa in group 
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D and E was increased significantly than that in the group 
B and C (P<0.05), and the distal mucosal pH dropped 
significantly in the group B and C (P<0.05) (Table 2).
Table 2
pH comparision of lower esophageal mucosa and the distal mucosa.
Groups n Lower esophageal mucosa Distal mucosa
Group A 10 6.03依0.22 1.82依0.20
Group B 10 2.39依0.32* 1.66依0.13
Group C 10 2.70依0.20* 1.67依0.55
Group D 10 5.96依0.46△ 1.28依0.38*△
Group E 10 6.06依0.58△ 1.10依0.20*△
note: *P＜0.05 compared with group A; △P＜0.05 compared 
with group B, C. 
3.4. Pathological observations of esophageal mucosa 
  Esophageal mucosa of group A, D, E was normal; 
hyperplasia of squamous esophageal mucosa was significant 
in Group B and C. Propria nipples was observed in mucosa 
lamina, inflammatory cells infiltrating, predominantly 
neutrophils and lymphocytes, was observed (Figure 1).
        Group A                                    Group B                                     Group C
 Group D                                              Group E
Figure 1.  Pathological observations of esophageal mucosa (HE×100).
4. Discussion
  The reflux esophagitis belongs to “noisy, spit acid, 
choking diaphragmatic” category in Chinese traditional 
medicine, related to many factors such as diet and mood. 
The pathogenesis is that the gastric estrangement and 
liver-qi stasis, resulting in liver-qi depression, dampness 
and heat cements in the liver[11-15]. Acid reflux can cause 
burning pain of diaphragm, which would progress into choke 
symptoms[16,17]. In view of the fact that this disease is mainly 
caused by spleen deficient, weak stomach, obstructed 
phlegm, etc. So based on the theory of Chinese medicine that 
digestive organs should have harmonious relationship[18], we 
chose Xuanfudaizhetang to treat rats with reflux esophagitis, 
and obtained good effect.
  Inula flower can cause gas saliva inversion and sputum 
elimination. The official medicine red ocher can treat 
hiccups and belching, the adjuvant medicine ginger can 
warm the stomach phlegm, pinellia can inverse the stomach. 
Combination use of these ingredients can decrease the 
acid damage[19-24]. Modern pharmacology showed that 
Xuanfudaizhetang can obviously enhance the gastrointestinal 
peristalsis, and increase a variety of amino acids and strong 
tonic, provide the body with sufficient nutritions to promote 
recovery of vital spirit[25-29]. In this study, after treatment, 
the weight gain of group E was significantly higher than that 
of group C, which was provided with saline (P<0.05), and its 
mechanism of action and the theory is the same. Research 
has shown that esophageal mucosa injury and symptoms in 
reflux esophagitis are pH dependent, frequency and contact 
time with acid exposure is also closely related to reflux 
esophagitis. Acid reflux can cause the direct damage in 
reflux esophagitis when esophageal pH is less than 4, play 
an important role in the pathogenesis of reflux esophagitis[30-
32]. In this experiment, lower esophageal pH in group E 
rats is significantly higher than group C (model group) and 
group B (placebo), suggesting that Xuanfudaizhetang can 
obviously improve the pH of lower esophageal mucosa in 
rats with reflux esophagitis, decrease pH value of gastric 
mucosal, thus improve reflux esophagitis pathological 
state. Xuanfudaizhetang and motilium can improve pH 
value of lower esophageal mucosal, which may be related 
to promoting anterograde peristalsis of oesophagus and 
stomach, as well as inhibition of gastric acid secretion and 
so on[33,34].
  The experimental results showed that compared with 
group B and C, pH of lower esophageal mucosa of rats of 
group D increased significantly after treatment for a week. It 
suggests that Xuanfudaizhetang can increase the pH value 
of the lower esophageal mucosa and reduce inflammation 
stimulation, so as to protect the esophageal mucosa, it can 
also significantly stimulate the secretion of gastrin and 
gastric acid, reduce gastric pH value to improve pathological 
condition of esophageal mucosa in reflux esophagitis 
treatment.
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